paxilline has been researched along with Skin Neoplasms in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Harada, Y; Isei, T; Kanto, N; Maeda, K; Ohe, S; Ohkawa, Y; Tachibana, K; Taniguchi, N | 1 |
| Furukawa, K; Hamamura, K; Miyata, M; Miyazaki, S; Ohkawa, Y | 1 |
| Clark, E; Eskandarpour, M; Hansson, J; Huang, F; Reeves, KA | 1 |
| Elbling, L; Fiebiger, E; Gerner, C; Jäger, W; Kunstfeld, R; Mikula, M; Paulitschke, V; Pehamberger, H; Riemer, AB; Scheiner, O; Schicher, N; Swoboda, A; Szekeres, T; Trimurtulu, G; Venkateswarlu, S | 1 |
| Bode, AM; Cho, YY; Dong, Z; He, Z; Mizuno, H; Seok Choi, H; Tatsumi, Y | 1 |
| Newell, SW; Perchellet, EM; Perchellet, JP; Ulug, ET | 1 |
6 other study(ies) available for paxilline and Skin Neoplasms
| Article | Year |
|---|---|
The expression of keratan sulfate in malignant melanoma enhances the adhesion and invasion activity of melanoma cells.
Topics: Cell Line, Tumor; Glycolipids; Humans; Keratan Sulfate; Melanoma; Melanoma, Cutaneous Malignant; Paxillin; Proteoglycans; Skin Neoplasms | 2022 |
Essential roles of integrin-mediated signaling for the enhancement of malignant properties of melanomas based on the expression of GD3.
Topics: Cell Adhesion; Cell Line, Tumor; Cell Proliferation; Crk-Associated Substrate Protein; Extracellular Matrix; Focal Adhesions; Gangliosides; Humans; Integrin beta1; Melanoma; Neoplasm Invasiveness; Paxillin; Phosphorylation; Signal Transduction; Skin Neoplasms | 2008 |
Oncogenic NRAS has multiple effects on the malignant phenotype of human melanoma cells cultured in vitro.
Topics: Cell Adhesion Molecules; Cell Line, Tumor; Cyclin D1; Cyclins; Cytoskeleton; Gene Expression Regulation, Neoplastic; Genes, ras; Humans; Melanoma; Mutation; Oncogene Protein p21(ras); Paxillin; Phenotype; Phosphoproteins; Skin Neoplasms; Vinculin | 2009 |
3,3',4,4',5,5'-hexahydroxystilbene impairs melanoma progression in a metastatic mouse model.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p21; Disease Models, Animal; Disease Progression; DNA Damage; Dose-Response Relationship, Drug; Female; Humans; Melanoma; Mice; Mice, SCID; Paxillin; Pyrogallol; Skin Neoplasms; Stilbenes; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2010 |
Involvement of the paxillin pathway in JB6 Cl41 cell transformation.
Topics: Animals; Base Sequence; Cell Growth Processes; Cell Line; Cell Transformation, Neoplastic; Down-Regulation; Epidermal Growth Factor; MAP Kinase Kinase 4; Mice; Molecular Sequence Data; Paxillin; Phosphorylation; Proto-Oncogene Proteins c-jun; RNA, Small Interfering; Serine; Skin; Skin Neoplasms; Tetradecanoylphorbol Acetate; Transfection | 2006 |
Alterations in focal adhesion kinase activity and associated proteins during malignant conversion of mouse keratinocytes.
Topics: Animals; Blotting, Western; Calcium; Cell Adhesion Molecules; Cell Differentiation; Cell Line; Cell Line, Transformed; Cell Transformation, Neoplastic; Cytoskeletal Proteins; Enzyme Activation; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Immunohistochemistry; Integrin beta1; Keratinocytes; Mice; Neoplasm Metastasis; Papilloma; Paxillin; Phosphoproteins; Phosphorylation; Precipitin Tests; Protein Binding; Protein-Tyrosine Kinases; Skin Neoplasms | 1999 |